Impact of the Cu(II) ions on the chemical and biological properties of goserelin - coordination pattern, DNA degradation, oxidative reactivity and in vitro cytotoxicity.
暂无分享,去创建一个
Robert Wieczorek | R. Wieczorek | A. Kyzioł | K. Stokowa-Sołtys | M. Jeżowska‐Bojczuk | Paulina K Walencik | Kamila Stokowa-Sołtys | Urszula K Komarnicka | Agnieszka Kyzioł | Małgorzata Jeżowska-Bojczuk | U. K. Komarnicka | Paulina K. Walencik
[1] R. Martin,et al. Visible circular dichroism of copper(II) complexes of amino acids and peptides. , 1970, Journal of the American Chemical Society.
[2] Wan-Xi Yang,et al. Molecular regulation of hypothalamus-pituitary-gonads axis in males. , 2014, Gene.
[3] W. Crowley,et al. The study of GnRH control of reproductive function. , 1984, Upsala journal of medical sciences.
[4] R. Kühne,et al. Antagonist and agonist binding models of the human gonadotropin-releasing hormone receptor. , 2005, Biochemical and biophysical research communications.
[5] K. Goa,et al. Nafarelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical potential in sex hormone-related conditions. , 1990, Drugs.
[6] H. Kozłowski,et al. 2-(Hydroxyimino)propanohydroxamic acid, a new effective ligand for aluminium , 2000 .
[7] M. Jeżowska‐Bojczuk,et al. Coordination versatility of phosphine derivatives of fluoroquinolones. New CuI and CuII complexes and their interactions with DNA , 2015 .
[8] A. Padula. GnRH analogues--agonists and antagonists. , 2005, Animal reproduction science.
[9] A. Kyzioł,et al. Copper(I) complexes with phosphine derived from sparfloxacin. Part II: a first insight into the cytotoxic action mode. , 2016, Dalton transactions.
[10] H. Kozłowski,et al. Coordination ability of the thyrotropin releasing factor. I. Interactions with cupric ions , 1979 .
[11] I. Voutsadakis,et al. Hormone Receptors in Serous Ovarian Carcinoma: Prognosis, Pathogenesis, and Treatment Considerations , 2016, Clinical Medicine Insights. Oncology.
[12] H. Schugar,et al. Charge-transfer absorptions of copper(II)-imidazole and copper(II)-imidazolate chromophores , 1980 .
[13] J. Slingerland,et al. Links between oestrogen receptor activation and proteolysis: relevance to hormone-regulated cancer therapy , 2013, Nature Reviews Cancer.
[14] A. Albert,et al. 455. The strength of heterocyclic bases , 1948 .
[15] H. Kozłowski,et al. Binding of Cu2+, Zn2+, and Ni(2+)-GnRH complexes with the rat pituitary receptor. , 1997, Journal of inorganic biochemistry.
[16] Rory Stark. Differential Oestrogen Receptor Binding is Associated with Clinical Outcome in Breast Cancer , 2012, RECOMB.
[17] P. Młynarz,et al. Structural analysis and sheep pituitary receptor binding of GnRH and its complexes with metal ions. , 2003, Journal of inorganic biochemistry.
[18] B. Halliwell,et al. Free radicals in biology and medicine , 1985 .
[19] A. Scozzafava,et al. A thermodynamic and spectroscopic study of the complexes of the undecapeptide Substance P, of its N-terminal fragment and of model pentapeptides containing two prolyl residues with copper ions , 1991 .
[20] Helmut Sigel,et al. Coordinating properties of the amide bond. Stability and structure of metal ion complexes of peptides and related ligands , 1982 .
[21] H. Kozłowski,et al. Specific structure–stability relations in metallopeptides , 1999 .
[22] D. Truhlar,et al. The M06 suite of density functionals for main group thermochemistry, thermochemical kinetics, noncovalent interactions, excited states, and transition elements: two new functionals and systematic testing of four M06-class functionals and 12 other functionals , 2008 .
[23] M. Dowsett,et al. Influence of sex hormones on cancer progression. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] H. Kozłowski,et al. Further structural analysis of GnRH complexes with metal ions. , 2005, Neuro endocrinology letters.
[25] P. Leung,et al. Targeting gonadotropin-releasing hormone receptor inhibits the early step of ovarian cancer metastasis by modulating tumor-mesothelial adhesion. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.
[26] M. Tacke,et al. Bioorganometallic fulvene-derived titanocene anti-cancer drugs. , 2008, Chemical Society reviews.
[27] H. Schugar,et al. Electronic spectra of copper(II)-imidazole and copper(II)-pyrazole chromophores , 1981 .
[28] A. Sharma,et al. Gonadotropin-releasing hormone analogs: Understanding advantages and limitations , 2014, Journal of human reproductive sciences.
[29] T. Kiss,et al. Studies on transition-metal–peptide complexes. Part 12. Copper(II) complexes of dipeptides containing phenylalanine and tyrosine , 1986 .
[30] Jochen Spiegel,et al. Azapeptides and their therapeutic potential. , 2011, Future medicinal chemistry.
[31] H. Kozłowski,et al. Gonadoliberin (GnRH) and its copper complex (Cu-GnRH) enzymatic degradation in hypothalamic and pituitary tissue in vitro. , 2012, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
[32] M. Motta,et al. GnRH receptors in cancer: from cell biology to novel targeted therapeutic strategies. , 2012, Endocrine reviews.
[33] M. Brattain,et al. Establishment of Mouse Colonie Carcinoma Cell Lines with Different Metastatic Properties1 , 1980 .
[34] Leighton J. Core,et al. A Rapid, Extensive, and Transient Transcriptional Response to Estrogen Signaling in Breast Cancer Cells , 2011, Cell.
[35] M. Huerta-Reyes,et al. Human gonadotropin-releasing hormone receptor-activated cellular functions and signaling pathways in extra-pituitary tissues and cancer cells (Review). , 2009, Oncology reports.
[36] Y. Nishida,et al. Splitting of d-orbitals in square planar complexes of copper(II), nickel(II) and cobalt(II) , 1979 .
[37] P. Wise,et al. The role of the brain in female reproductive aging , 2009, Molecular and Cellular Endocrinology.
[38] E. H. Strickland,et al. Aromatic contributions to circular dichroism spectra of proteins. , 1974, CRC critical reviews in biochemistry.
[39] H. Kozłowski,et al. How non-bonding amino acid side-chains may enormously increase the stability of a Cu(II)—peptide complex , 1998 .
[40] Sanford A. Asher,et al. UV resonance Raman excitation profiles of the aromatic amino acids , 1986 .
[41] R. Dyball,et al. Evidence for a direct effect of LRF and TRF on single unit activity in the rostral hypothalamus , 1974, Nature.
[42] N. C. Price,et al. How to study proteins by circular dichroism. , 2005, Biochimica et biophysica acta.
[43] H. Xu,et al. Androgen receptor: structure, role in prostate cancer and drug discovery , 2014, Acta Pharmacologica Sinica.
[44] Rory Stark,et al. Progesterone receptor modulates estrogen receptor-α action in breast cancer , 2015, Nature.
[45] R. Wieczorek,et al. Infrared matrix isolation and ab initio studies on isothiocyanic acid HNCS and its complexes with nitrogen and xenon , 2003 .
[46] T. Plant. 60 YEARS OF NEUROENDOCRINOLOGY: The hypothalamo-pituitary-gonadal axis. , 2015, The Journal of endocrinology.
[47] R. Millar. GnRHs and GnRH receptors. , 2005, Animal reproduction science.
[48] Andreas Zimmer,et al. A practical note on the use of cytotoxicity assays. , 2005, International journal of pharmaceutics.
[49] H. Kozłowski,et al. The impact of the amino-acid sequence on the specificity of copper[II] interactions with peptides having nonco-ordinating side-chains , 1997 .
[50] A. Mehta,et al. Engineering metal ion coordination to regulate amyloid fibril assembly and toxicity , 2007, Proceedings of the National Academy of Sciences.
[51] Paul J Hergenrother,et al. DNA as a target for anticancer compounds: methods to determine the mode of binding and the mechanism of action. , 2007, Current opinion in biotechnology.
[52] J. Carroll,et al. Pioneer factors in hormone-dependent cancers , 2012, Nature Reviews Cancer.
[53] Z. Latajka,et al. Ab initio calculations and matrix infrared spectra of the nitrous acid complexes with HF and HCl , 1999 .
[54] A. Schally,et al. The identity of chemical and hormonal properties of the thyrotropin releasing hormone and pyroglutamyl-histidyl-proline amide. , 1969, Biochemical and biophysical research communications.
[55] M. Brattain,et al. Establishment of mouse colonic carcinoma cell lines with different metastatic properties. , 1980, Cancer research.
[56] A. Navratil,et al. Effects of Gonadotrophin‐Releasing Hormone Outside the Hypothalamic‐Pituitary‐Reproductive Axis , 2009, Journal of neuroendocrinology.
[57] H. Kozłowski,et al. Metal complexes of luteinizing hormone-releasing hormone (LHRH). potentiometric and spectroscopic studies. , 1988, Journal of inorganic biochemistry.
[58] L. W. Cheung,et al. Gonadotropin‐releasing hormone: GnRH receptor signaling in extrapituitary tissues , 2008, The FEBS journal.
[59] H. Xu. Family reunion of nuclear hormone receptors: structures, diseases, and drug discovery , 2015, Acta Pharmacologica Sinica.